Results 151 to 160 of about 581,626 (194)
Transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic option for high-risk aortic stenosis. Malposition of the prosthesis and severe residual aortic regurgitation are known complications of the procedure, which might require a ...
core
TAVI: Transcatheter Aortic Valve Implantation
Neal, Kleiman, Michael J, Reardon
openaire +2 more sources
Transcatheter aortic valve implantation in young
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Transcatheter Aortic Valve Implantation
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2009There has been significant improvement in device designs, operative techniques, and early clinical outcomes in <5 years. Presently, there are two catheter-based bioprostheses (balloon expandable or self-expandable), which have been widely used in humans and are undergoing clinical investigations.
Jian, Ye, Samuel V, Lichtenstein
+7 more sources
Transcatheter Aortic Valve Implantation
Cardiology Clinics, 2010In the 7 years since the first implant, more than 7000 transcatheter aortic valve implantations (TAVI) have been performed worldwide. This article describes the latest available information on this field and the upcoming technological expectations.
Raquel, Del Valle-Fernández +2 more
openaire +2 more sources
Transcatheter Aortic Valve Implantation
Current Atherosclerosis Reports, 2016Severe aortic stenosis (AS) is a life-threatening condition when left untreated. Aortic valve replacement (AVR) is the gold standard treatment for the majority of patients; however, transcatheter aortic valve implantation/replacement (TAVI/TAVR) has emerged as the preferred treatment for high-risk or inoperable patients.
S Chris, Malaisrie +3 more
openaire +2 more sources
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis [PDF]
AIMS Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) vs.
Fabien Praz +2 more
exaly +3 more sources
Transcatheter Aortic Valve Implantation in Aortic Coarctation
The Thoracic and Cardiovascular Surgeon, 2012A 77-year-old male patient was scheduled for transcatheter aortic valve implantation for symptomatic and severe aortic valve stenosis. Severe multidirectional kinking of the aorta based on aortic coarctation did not allow for the transfemoral, but only for the transapical approach.
René, Schramm +6 more
openaire +2 more sources
Transcatheter aortic valve implantation and frailty
Cardiovascular Intervention and Therapeutics, 2022Over the last decade, transcatheter aortic valve implantation (TAVI) has emerged as a treatment option for patients with severe aortic stenosis. With exponential increase in the number of TAVI procedures, frailty assessments have been considered important for patients undergoing TAVI, and a number of studies have indicated a relationship between the ...
Tetsuro, Shimura, Masanori, Yamamoto
openaire +2 more sources
Transcatheter aortic valve implantation: the evidence
Heart, 2012Transcatheter aortic valve implantation (TAVI) is the new standard-of-care for inoperable patients with better outcome than conservative management, including balloon valvuloplasty only. In high-risk patients, TAVI has clearly shown non-inferiority compared with surgical aortic valve replacement.
Jan-Malte, Sinning +3 more
openaire +2 more sources

